{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T11:29:30Z","timestamp":1793532570214,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010529"],"award-info":[{"award-number":["2023A1515010529"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017689","name":"Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A04J0524"],"award-info":[{"award-number":["2023A04J0524"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A04J0507"],"award-info":[{"award-number":["2023A04J0507"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A04J0523"],"award-info":[{"award-number":["2023A04J0523"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203080"],"award-info":[{"award-number":["82203080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202055"],"award-info":[{"award-number":["82202055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203081"],"award-info":[{"award-number":["82203081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146390","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T23:47:16Z","timestamp":1753832836000},"page":"146390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P3","title":["GPRC5A modulates resistance to temozolomide in glioblastoma through glycolytic reprogramming"],"prefix":"10.1016","volume":"321","author":[{"given":"Wahafu","family":"Alafate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichao","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengpan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146390_bb0005","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/neuonc\/noae085","article-title":"Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients","volume":"26","author":"Hendriksen","year":"2024","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146390_bb0010","first-page":"383","article-title":"The angiogenic switch leads to a metabolic shift in human glioblastoma","volume":"19","author":"Talasila","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146390_bb0015","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300724R","article-title":"CircMTA1 promotes glioblastoma angiogenesis by encoding MTA1-134aa","volume":"37","author":"Niu","year":"2023","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146390_bb0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.15690\/vramn.v68i11.851","article-title":"VEGFRs in neoplastic angiogenesis and prospects for therapy of brain tumors","author":"Korchagina","year":"2013","journal-title":"Vestn. Ross. Akad. Med. Nauk"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0025","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s12035-020-01892-8","article-title":"Tumor Development and Angiogenesis in Adult Brain Tumor: Glioblastoma","volume":"57","author":"Ahir","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00488","article-title":"An Inflammatory Landscape for Preoperative Neurologic Deficits in Glioblastoma","volume":"10","author":"Katrib","year":"2019","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146390_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000525651","article-title":"Symptom Burden in Glioblastoma: A Prospective Pilot Study from Diagnosis to First Progression","volume":"101","author":"Roelcke","year":"2023","journal-title":"Oncology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0040","first-page":"6641","article-title":"Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: Case report and review of the literature","volume":"15","author":"Prelaj","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.neuroscience.2022.03.030","article-title":"Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme","volume":"491","author":"Aldoghachi","year":"2022","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146390_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11061579","article-title":"Personalized treatment of glioblastoma: current state and future perspective","volume":"11","author":"Roncevic","year":"2023","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146390_bb0055","doi-asserted-by":"crossref","first-page":"12327","DOI":"10.1007\/s13277-014-2545-1","article-title":"Annexin A5 promotes invasion and chemoresistance to temozolomide in glioblastoma multiforme cells","volume":"35","author":"Wu","year":"2014","journal-title":"Tumour Biol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146390_bb0060","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.10798","article-title":"LGR6 promotes glioblastoma malignancy and chemoresistance by activating the Akt signaling pathway","volume":"22","author":"Cheng","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2018.10.063","article-title":"Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions","volume":"109","author":"Zhang","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146390_bb0070","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jocn.2009.09.004","article-title":"Survival comparison between glioblastoma multiforme and other incurable cancers","volume":"17","author":"Tran","year":"2010","journal-title":"J. Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146390_bb0075","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-020-03451-6","article-title":"Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis","volume":"147","author":"Marenco-Hillembrand","year":"2020","journal-title":"J. Neuro-Oncol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146390_bb0080","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.7150\/jca.93217","article-title":"Exploring the Prognostic Value and Immune Infiltration Patterns of GPRC5A Across Multiple Cancer Types","volume":"15","author":"Hu","year":"2024","journal-title":"J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.624493","article-title":"GPRC5A is a negative regulator of the pro-survival PI3K\/Akt signaling pathway in triple-negative breast cancer","volume":"10","author":"Yang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101063","article-title":"Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer","volume":"73","author":"Ou","year":"2024","journal-title":"Drug Resist. Updat."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0095","article-title":"Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via the cAMP-CREB axis","volume":"14","author":"Fang","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0100","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.PANCA16-A41","article-title":"GPRC5A acts as a potent oncogene in pancreatic cancer","volume":"76","author":"Zhou","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00431","article-title":"GPCRomics: GPCR expression in cancer cells and tumors identifies new, potential biomarkers and therapeutic targets","volume":"9","author":"Insel","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146390_bb0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/bcb-2022-0352","article-title":"The G protein-coupled receptor GPRC5A--a phorbol ester and retinoic acid-induced orphan receptor with roles in cancer, inflammation, and immunity","volume":"101","author":"Gonz\u00e1lez","year":"2023","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.biochi.2019.04.010","article-title":"GLUT1 is associated with sphingolipid-organized, cholesterol-independent domains in L929 mouse fibroblast cells","volume":"162","author":"Rylaarsdam","year":"2019","journal-title":"Biochimie"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146390_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091308","article-title":"GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets","volume":"11","author":"Guda","year":"2019","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02927-3","article-title":"AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth","volume":"42","author":"Yun","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"29","key":"10.1016\/j.ijbiomac.2025.146390_bb0130","doi-asserted-by":"crossref","first-page":"46335","DOI":"10.18632\/oncotarget.10114","article-title":"Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas","volume":"7","author":"Miranda-Gon\u00e7alves","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123544","article-title":"Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma","volume":"10","author":"Sanzey","year":"2015","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.146390_bb0140","doi-asserted-by":"crossref","first-page":"20639","DOI":"10.1002\/cam4.6627","article-title":"Warburg effect-related risk scoring model to assess clinical significance and immunity characteristics of glioblastoma","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146390_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13143468","article-title":"MCT1 is a new prognostic biomarker and its therapeutic inhibition boosts response to Temozolomide in human glioblastoma","volume":"13","author":"Miranda-Gon\u00e7alves","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146390_bb0150","first-page":"1599","article-title":"Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment","volume":"6","author":"Labak","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146390_bb0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nchembio.1986","article-title":"Correlating chemical sensitivity and basal gene expression reveals mechanism of action","volume":"12","author":"Rees","year":"2016","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gpb.2020.10.005","article-title":"Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients","volume":"19","author":"Zhao","year":"2021","journal-title":"Genom. Proteom. Bioinform."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.146390_bb0165","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1158\/0008-5472.CAN-09-2307","article-title":"Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology","volume":"69","author":"Gravendeel","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.158","article-title":"The REMBRANDT study, a large collection of genomic data from brain cancer patients","volume":"5","author":"Gusev","year":"2018","journal-title":"Sci. Data"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0175","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41419-024-06735-1","article-title":"Targeting ARNT attenuates chemoresistance through destabilizing p38alpha-MAPK signaling in glioblastoma","volume":"15","author":"Alafate","year":"2024","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146390_bb0180","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217067","article-title":"GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2-STAT3 pathway","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"8016","key":"10.1016\/j.ijbiomac.2025.146390_bb0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"Pt 6","key":"10.1016\/j.ijbiomac.2025.146390_bb0195","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1107\/S2059798322002741","article-title":"Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap","volume":"78","author":"Jones","year":"2022","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0200","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.12688\/f1000research.26932.1","article-title":"Recognizing the value of software: a software citation guide","volume":"9","author":"Katz","year":"2020","journal-title":"F1000Res"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146390_bb0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40617-021-00664-7","article-title":"Using GraphPad Prism\u2019s heat maps for efficient, fine-grained analyses of single-case data","volume":"15","author":"Mitteer","year":"2022","journal-title":"Behav. Anal. Pract."},{"issue":"7216","key":"10.1016\/j.ijbiomac.2025.146390_bb0210","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"N. Cancer Genome Atlas Research","year":"2008","journal-title":"Nature"},{"issue":"W1","key":"10.1016\/j.ijbiomac.2025.146390_bb0215","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/cncr.25581","article-title":"Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis","volume":"117","author":"Pallini","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/jclinpath-2017-204815","article-title":"Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: a review","volume":"71","author":"van Schaijik","year":"2018","journal-title":"J. Clin. Pathol."},{"issue":"D1","key":"10.1016\/j.ijbiomac.2025.146390_bb0230","doi-asserted-by":"crossref","first-page":"D1429","DOI":"10.1093\/nar\/gkad820","article-title":"SORC: an integrated spatial omics resource in cancer","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0235","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s11011-023-01207-5","article-title":"Functional importance of glucose transporters and chromatin epigenetic factors in Glioblastoma Multiforme (GBM): possible therapeutics","volume":"38","author":"Chamarthy","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2023.101836","article-title":"Mitochondrial mechanisms in temozolomide resistance: unraveling the complex interplay and therapeutic strategies in glioblastoma","volume":"75","author":"Li","year":"2024","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0245","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/ijc.32554","article-title":"GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer","volume":"146","author":"Sawada","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0250","article-title":"Epigenetic Underpinnings of Inflammation: A Key to Unlock the Tumor Microenvironment in Glioblastoma","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146390_bb0255","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3892\/or.2016.5062","article-title":"GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway","volume":"36","author":"Yang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146390_bb0260","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1002\/ijc.28569","article-title":"High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients","volume":"134","author":"Sokolenko","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146390_bb0265","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.7150\/jca.52578","article-title":"GPRC5A: an emerging prognostic biomarker for predicting malignancy of pancreatic cancer based on bioinformatics analysis","volume":"12","author":"Qian","year":"2021","journal-title":"J. Cancer"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146390_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19071870","article-title":"The Effect of GPRC5a on the Proliferation, Migration Ability, Chemotherapy Resistance, and Phosphorylation of GSK-3\u03b2 in Pancreatic Cancer","volume":"19","author":"Liu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170390","article-title":"The G protein-coupled receptor RAI3 is an independent prognostic factor for pancreatic cancer survival and regulates proliferation via STAT3 phosphorylation","volume":"12","author":"Jahny","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0280","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-022-02466-5","article-title":"DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer","volume":"22","author":"Liu","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146390_bb0285","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101736R","article-title":"A positive feedback circuit comprising p21 and HIF-1\u03b1 aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1\/LDHA-mediated glycolysis","volume":"36","author":"Jin","year":"2022","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0290","article-title":"DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154176","article-title":"SREBP2\/Rab11s\/GLUT1\/6 network regulates proliferation and migration of glioblastoma","volume":"240","author":"Cheng","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0300","article-title":"Screening of predicted synergistic multi-target therapies in glioblastoma identifies new treatment strategies","volume":"5","author":"Houweling","year":"2023","journal-title":"Neuro-Oncol. Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146390_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202300315","article-title":"The Power of Synergism: A Novel Drug Combination for Improved Therapy of Glioblastoma","volume":"7","author":"Maravajjala","year":"2024","journal-title":"Adv. Therap."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146390_bb0310","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-022-02251-2","article-title":"Immunotherapy for glioblastoma: the promise of combination strategies","volume":"41","author":"Bausart","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.146390_bb0315","article-title":"Glioma Stem Cells: GPRC5A as a Novel Predictive Biomarker and Therapeutic Target Associated with Mesenchymal and Stemness Features","volume":"14","author":"Aghamiri","year":"2024","journal-title":"Appl. Sci.-Basel"},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0320","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/2152-7806.132138","article-title":"Glioblastoma multiforme: State of the art and future therapeutics","volume":"5","author":"Wilson","year":"2014","journal-title":"Surg. Neurol. Int."},{"issue":"18","key":"10.1016\/j.ijbiomac.2025.146390_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814256","article-title":"Understanding glioblastoma signaling, heterogeneity, invasiveness, and drug delivery barriers","volume":"24","author":"Rabah","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.146390_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00494","article-title":"The Intratumoral Heterogeneity Reflects the Intertumoral Subtypes of Glioblastoma Multiforme: A Regional Immunohistochemistry Analysis","volume":"10","author":"Bergmann","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146390_bb0335","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cam4.219","article-title":"U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells","volume":"3","author":"Torsvik","year":"2014","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146390_bb0340","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/2211-5463.13894","article-title":"Identifying adeno-associated virus (AAV) vectors that efficiently target high grade glioma cells, for in vitro monitoring of temporal cell responses","volume":"14","author":"Sarker","year":"2024","journal-title":"FEBS Open Bio."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025069478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025069478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T04:07:04Z","timestamp":1756094824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025069478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":68,"alternative-id":["S0141813025069478"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146390","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GPRC5A modulates resistance to temozolomide in glioblastoma through glycolytic reprogramming","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"146390"}}